| 别名 | ;['Coumarin 30', '3-(2-', 'N', '-Methylbenzimidazolyl)-7-', 'N', ',', 'N', '-diethylaminocoumarin'] |
7-二乙氨基-3-(1-甲基-2-苯并咪唑基)香豆素
7-(Diethylamino)-3-(1-methyl-2-benzimidazolyl)coumarin （订货以英文为准）
编号：D154271
CAS号：41044-12-6
分子式：C21H21N3O2
分子量：347.41
| 产品名称 | 7-(Diethylamino)-3-(1-methyl-2-benzimidazolyl)coumarin |
| 中文名称 | 7-二乙氨基-3-(1-甲基-2-苯并咪唑基)香豆素 |
| CAS号 | 41044-12-6 |
| MDL编码 | D154271 |
| 分子式（M.F.） | C21H21N3O2 |
| 分子量（M.W.） | 347.41 |
| Reaxys-RN | 16526752 |
技术规格
| Background: | Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S preinitiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. |
| Applications: | WB, IHC |
| Name of antibody: | EIF3I |
| Immunogen: | Fusion protein of human EIF3I |
| Full name: | eukaryotic translation initiation factor 3, subunit I |
| Synonyms： | TRIP1; EIF3S2; TRIP-1; PRO2242; eIF3-p36; eIF3-beta |
| SwissProt: | Q13347 |
| IHC positive control: | Human liver cancer |
| IHC Recommend dilution: | 10-50 |
| WB Predicted band size: | 37 kDa |
| WB Positive control: | K562 cell |
| WB Recommended dilution: | 200-1000 |
搜索质检报告(COA)
搜索MSDS
相关产品
党沛 
